{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:39:22Z","timestamp":1770331162505,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272753"],"award-info":[{"award-number":["82272753"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Collaborative Academic Innovation Project of Shandong Cancer Hospital","award":["ZF004"],"award-info":[{"award-number":["ZF004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-026-02786-0","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:34:29Z","timestamp":1768041269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postoperative recurrence patterns and anatomy-stratified clinical target volume delineation in pancreatic cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Yunfan","family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyu","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbo","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"2786_CR1","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: A pooled analysis of 17 Population-Based cancer registries. Lancet Global Health. 2018;6:e555\u201367.","journal-title":"Lancet Global Health"},{"key":"2786_CR2","unstructured":"Five-year survival for pancreatic cancer has risen to 13%. (2024, January 18) retrieved 16 March 2025 from https:\/\/medicalxpress.com\/news\/2024-01-year-survival-pancreatic-cancer-risen.html"},{"issue":"5","key":"2786_CR3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.prro.2019.06.016","volume":"9","author":"M Palta","year":"2019","unstructured":"Palta M, et al. Radiation therapy for pancreatic cancer: executive summary of an ASTRO clinical practice guideline. Practical Radiation Oncol Vol. 2019;9(5):322\u201332. https:\/\/doi.org\/10.1016\/j.prro.2019.06.016.","journal-title":"Practical Radiation Oncol Vol"},{"key":"2786_CR4","doi-asserted-by":"publisher","first-page":"1473e1481","DOI":"10.1001\/jama.2013.279201","volume":"310","author":"H Oettle","year":"2013","unstructured":"Oettle H, Neuhaus P, Hochhaus A, et al. Adjuvant chemo-therapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013;310:1473e1481.","journal-title":"JAMA"},{"key":"2786_CR5","doi-asserted-by":"publisher","first-page":"908e915","DOI":"10.1038\/sj.bjc.6605256","volume":"101","author":"H Ueno","year":"2009","unstructured":"Ueno H, Kosuge T, Matsuyama Y, et al. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese study group of adjuvant therapy for pancreatic cancer. Br J Cancer. 2009;101:908e915.","journal-title":"Br J Cancer"},{"key":"2786_CR6","doi-asserted-by":"publisher","first-page":"246e250","DOI":"10.1038\/sj.bjc.6604838","volume":"100","author":"JP Neoptolemos","year":"2009","unstructured":"Neoptolemos JP, Stocken DD, Tudur Smith C, et al. Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and-3(v1) trials. Br J Cancer. 2009;100:246e250.","journal-title":"Br J Cancer"},{"key":"2786_CR7","doi-asserted-by":"publisher","first-page":"776e782","DOI":"10.1097\/00000658-199912000-00006","volume":"230","author":"JH Klinkenbijl","year":"1999","unstructured":"Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal tract cancer cooperative group. Ann Surg. 1999;230:776e782. discussion 782e784.","journal-title":"Ann Surg"},{"key":"2786_CR8","doi-asserted-by":"publisher","first-page":"1200e1210","DOI":"10.1056\/NEJMoa032295","volume":"350","author":"JP Neoptolemos","year":"2004","unstructured":"Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200e1210.","journal-title":"N Engl J Med"},{"key":"2786_CR9","first-page":"65e88","volume":"196","author":"A Sultana","year":"2012","unstructured":"Sultana A, Cox T, Ghaneh P, Neoptolemos JP. Adjuvant therapy for pancreatic cancer. Recent Results Cancer Res. 2012;196:65e88.","journal-title":"Recent Results Cancer Res"},{"key":"2786_CR10","doi-asserted-by":"publisher","first-page":"684e692","DOI":"10.1159\/000320099","volume":"28","author":"A Thomas","year":"2010","unstructured":"Thomas A, Dajani K, Neoptolemos JP, Ghaneh P. Adjuvant therapy in pancreatic cancer. Dig Dis. 2010;28:684e692.","journal-title":"Dig Dis"},{"key":"2786_CR11","doi-asserted-by":"publisher","first-page":"1007e1015","DOI":"10.1016\/j.ijrobp.2013.09.005","volume":"87","author":"AS Dholakia","year":"2013","unstructured":"Dholakia AS, Kumar R, Raman SP, et al. Mapping patterns of local recurrence after pancreaticoduodenectomy for pancreatic adenocarcinoma: a new approach to adjuvant radiation field design. Int J Radiat Oncol Biol Phys. 2013;87:1007e1015.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2786_CR12","doi-asserted-by":"publisher","unstructured":"Sun Y, et al. Hallmarks of perineural invasion in pancreatic ductal adenocarcinoma: new biological dimensions. Front Oncol. 2024 Jul 25;14:1421067. https:\/\/doi.org\/10.3389\/fonc.2024.1421067","DOI":"10.3389\/fonc.2024.1421067"},{"key":"2786_CR13","doi-asserted-by":"publisher","unstructured":"Schorn S, et al. Neural invasion severity is a strong predictor of local recurrence in pancreatic ductal adenocarcinoma. Surgery. 2025;180:109018. https:\/\/doi.org\/10.1016\/j.surg.2024.109018","DOI":"10.1016\/j.surg.2024.109018"},{"issue":"11","key":"2786_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/jhbp.12056","volume":"31","author":"M Ishida","year":"2024","unstructured":"Ishida M, et al. Japanese classification of pancreatic carcinoma by the Japan pancreas society: eighth edition. J Hepato-Biliary-Pancreatic Sci. 2024;31(11):755\u201368. https:\/\/doi.org\/10.1002\/jhbp.12056.","journal-title":"J hepato-biliary-pancreatic Sci Vol"},{"issue":"3","key":"2786_CR15","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.ijrobp.2012.01.022","volume":"83","author":"KA Goodman","year":"2012","unstructured":"Goodman KA, et al. Radiation therapy oncology group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer. Int J Radiation Oncol Biology Phys Vol. 2012;83(3):901\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.01.022.","journal-title":"Int J Radiation Oncol Biology Phys Vol"},{"issue":"4","key":"2786_CR16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.ijrobp.2024.10.026","volume":"121","author":"NN Sanford","year":"2025","unstructured":"Sanford NN, et al. NRG oncology international consensus contouring atlas on target volumes and dosing strategies for Dose-Escalated pancreatic cancer radiation therapy. Int J Radiation Oncol Biology Phys Vol. 2025;121(4):918\u201329. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.026.","journal-title":"Int J Radiation Oncol Biology Phys Vol"},{"issue":"3","key":"2786_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.prro.2022.01.005","volume":"12","author":"CS Hill","year":"2022","unstructured":"Hill CS, Fu W, Hu C, et al. Location, Location, location: what should be targeted beyond gross disease for localized pancreatic ductal adenocarcinoma? Proposal of a standardized clinical tumor volume for pancreatic ductal adenocarcinoma of the head: the triangle volume. Pract Radiat Oncol. 2022;12(3):215\u201325. https:\/\/doi.org\/10.1016\/j.prro.2022.01.005.","journal-title":"Pract Radiat Oncol"},{"issue":"5","key":"2786_CR18","doi-asserted-by":"publisher","first-page":"101471","DOI":"10.1016\/j.adro.2024.101471","volume":"9","author":"EM Chung","year":"2024","unstructured":"Chung EM, Lu DJ, Nguyen AT, et al. Patterns of failure in patients with borderline Resectable\/Locally advanced pancreatic cancer after preoperative chemotherapy and stereotactic body radiation therapy. Adv Radiat Oncol. 2024;9(5):101471. https:\/\/doi.org\/10.1016\/j.adro.2024.101471. Published 2024 Feb 12.","journal-title":"Adv Radiat Oncol"},{"issue":"4","key":"2786_CR19","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.semradonc.2025.08.003","volume":"35","author":"A Narang","year":"2025","unstructured":"Narang A. Optimal target volume delineation for pancreatic cancer: triangulating what should be targeted. Semin Radiat Oncol. 2025;35(4):524\u20139. https:\/\/doi.org\/10.1016\/j.semradonc.2025.08.003.","journal-title":"Semin Radiat Oncol"},{"key":"2786_CR20","unstructured":"Liu WK, Tang BJ, Wang F, et al. Predicting early recurrence for resected pancreatic ductal adenocarcinoma: a multicenter retrospective study in China. Am J Cancer Res. 2021.11(6):3055\u201369."},{"key":"2786_CR21","doi-asserted-by":"crossref","unstructured":"Oladeru OT, Miccio JA, Yang J, et al. Conformal external beam radiation or selective internal radiation therapy-a comparison of treatment outcomes for hepatocellular carcinoma. J Gastrointest Oncol. 2016;7(3):433-440.21.","DOI":"10.21037\/jgo.2015.10.04"},{"issue":"5","key":"2786_CR22","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/MPA.0000000000001822","volume":"50","author":"G Lee","year":"2021","unstructured":"Lee G, Kim DW, Oladeru OT, et al. Liver metastasis-directed ablative radiotherapy in pancreatic cancer offers prolonged time off systemic therapy in selected patients: data from a multi-institutional retrospective study [J]. Pancreas. 2021;50(5):736\u201343.","journal-title":"Pancreas"},{"issue":"21","key":"2786_CR23","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1200\/JCO.2016.67.5553","volume":"34","author":"AA Khorana","year":"2016","unstructured":"Khorana AA, Mangu PB, Berlin J, et al. Potentially curable pancreatic cancer: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2016;34(21):2541\u201356. https:\/\/doi.org\/10.1200\/JCO.2016.67.5553.","journal-title":"J Clin Oncol"},{"key":"2786_CR24","doi-asserted-by":"crossref","unstructured":"Abrams RA, Winter KA, Goodman KA, Regine WF, Safran HP, Berger AC, Guha CS et al. NRG Oncology\/RTOG 0848: results after adjuvant chemotherapy\u2009\u00b1\u2009chemoradiation for patients with resected periampullary pancreatic adenocarcinoma (PA); results from node-negative subgroup. J Clin Oncol. 2024;42(16_suppl):4005.","DOI":"10.1200\/JCO.2024.42.16_suppl.4005"},{"key":"2786_CR25","doi-asserted-by":"publisher","unstructured":"Wang D, et al. Differences in the clinicopathological features of pancreatic head carcinoma in dorsal and ventral pancreas: a single institution retrospective review. Medicine. 2021;100(22):e26167. https:\/\/doi.org\/10.1097\/MD.0000000000026167","DOI":"10.1097\/MD.0000000000026167"},{"key":"2786_CR26","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1002\/bjs.10772","volume":"105","author":"SB Dreyer","year":"2018","unstructured":"Dreyer SB, et al. Defining the molecular pathology of pancreatic body and tail adenocarcinoma. Br J Surg. 2018;105:e183\u201391. https:\/\/doi.org\/10.1002\/bjs.10772.","journal-title":"Br J Surg Vol"},{"key":"2786_CR27","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","volume":"267","author":"VP Groot","year":"2018","unstructured":"Groot VP, Rezaee N, Wu W, Cameron JL, Fishman EK, Hruban RH, et al. Patterns, Timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg. 2018;267:936\u201345.","journal-title":"Ann Surg"},{"issue":"2","key":"2786_CR28","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.ijrobp.2023.06.230","volume":"117","author":"S Mao","year":"2023","unstructured":"Mao S, Lin TA, et al. Utilization of the triangle volume in patients with localized PDAC undergoing Pre-Operative SBRT: report of early outcomes. Int J Radiat Oncol Biol Phys. 2023;117(2):S14.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2786_CR29","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1016\/j.ijrobp.2025.06.1202","volume":"123","author":"AV Reddy","year":"2025","unstructured":"Reddy AV, Sehgal S, Paparoidamis G, Roche D, Kaplin D, Hacker-Prietz A, Roumeliotis MB, et al. A safety study of intraoperative radiation therapy following stereotactic body radiation therapy and Multi-Agent chemotherapy in the treatment of localized pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2025;123(1):S131.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2786_CR30","doi-asserted-by":"publisher","unstructured":"Yu W, et al. Pancreatic cancer adjuvant radiotherapy target volume design: based on the postoperative local recurrence spatial location. Radiat Oncol (London, England). 2016 Oct 19;11(1):138. https:\/\/doi.org\/10.1186\/s13014-016-0714-7","DOI":"10.1186\/s13014-016-0714-7"},{"key":"2786_CR31","doi-asserted-by":"publisher","unstructured":"Tanaka K, et al. Appropriate lymph node dissection sites for cancer in the body and tail of the pancreas: a multicenter retrospective study. Cancers. 2022 Sep 11;14(18):4409. https:\/\/doi.org\/10.3390\/cancers14184409","DOI":"10.3390\/cancers14184409"},{"issue":"11","key":"2786_CR32","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.hpb.2020.01.016","volume":"22","author":"J Navez","year":"2020","unstructured":"Navez J, et al. Distal pancreatectomy for pancreatic neoplasia: is splenectomy really necessary? A bicentric retrospective analysis of surgical specimens. HPB: Official J Int Hepato Pancreato Biliary Association. 2020;22(11):1583\u20139. https:\/\/doi.org\/10.1016\/j.hpb.2020.01.016.","journal-title":"HPB: Official J Int Hepato Pancreato Biliary Association Vol"},{"key":"2786_CR33","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.4240\/wjgs.v15.i6.1178","volume":"15","author":"Z Li","year":"2023","unstructured":"Li Z, et al. Dissimilar survival and clinicopathological characteristics of mucinous adenocarcinoma located in pancreatic head and body\/tail. World J Gastrointest Surg. 2023;15:1178\u201390. https:\/\/doi.org\/10.4240\/wjgs.v15.i6.1178.","journal-title":"World J Gastrointest Surg Vol"},{"issue":"12","key":"2786_CR34","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1080\/0284186X","volume":"57","author":"N van Erning, Felice","year":"2018","unstructured":"van Erning, Felice N, et al. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis. Acta Oncol (Stockholm Sweden). 2018;57(12):1655\u201362. https:\/\/doi.org\/10.1080\/0284186X.","journal-title":"Acta Oncol (Stockholm Sweden) Vol"},{"key":"2786_CR35","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1245\/s10434-017-6101-2","volume":"24","author":"YJ Jung","year":"2017","unstructured":"Jung YJ, Seo HS, Kim JH, Park CH, Lee HH. Cross-Sectional location of gastric cancer affects the Long-Term survival of patients as tumor invasion deepens. Ann Surg Oncol. 2017;24:3947\u201353. https:\/\/doi.org\/10.1245\/s10434-017-6101-2. PMID: 28980179.","journal-title":"Ann Surg Oncol"},{"key":"2786_CR36","doi-asserted-by":"publisher","unstructured":"Perkins CI, Hotes J, Kohler BA, Howe HL. Association between breast cancer laterality and tumor location, United: States, 1994\u20131998. Cancer Causes Control. 2004;15:637\u201345. https:\/\/doi.org\/10.1023\/B:CACO.0000036171.44162.5f. PMID: 15280621.","DOI":"10.1023\/B:CACO.0000036171.44162.5f"},{"key":"2786_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jss.2013.05.081","volume":"184","author":"M Bishawi","year":"2013","unstructured":"Bishawi M, Moore W, Bilfinger T. Severity of emphysema predicts location of lung cancer and 5-y survival of patients with stage I non-small cell lung cancer. J Surg Res. 2013;184:1\u20135. https:\/\/doi.org\/10.1016\/j.jss.2013.05.081. PMID: 23810745.","journal-title":"J Surg Res"},{"key":"2786_CR38","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.4143\/crt.2018.392","volume":"51","author":"CW Kim","year":"2019","unstructured":"Kim CW, Kim J, Park Y, Cho DH, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, Kim JC. Prognostic implications of: extranodal extension in relation to colorectal cancer location. Cancer Res Treat. 2019;51:1135\u201343. https:\/\/doi.org\/10.4143\/crt.2018.392. PMID:30514068.","journal-title":"Cancer Res Treat"},{"key":"2786_CR39","doi-asserted-by":"publisher","unstructured":"Kim HW, et al. Early versus delayed initiation of adjuvant treatment for pancreatic cancer. PloS One. 2017 Mar 16;12(3):e0173960. https:\/\/doi.org\/10.1371\/journal.pone.0173960","DOI":"10.1371\/journal.pone.0173960"},{"key":"2786_CR40","doi-asserted-by":"publisher","unstructured":"Ma SJ, et al. Association of timing of adjuvant therapy with survival in patients with resected stage I to II pancreatic cancer. JAMA Network Open. 2019 Aug 2;2(8):e199126. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.9126","DOI":"10.1001\/jamanetworkopen.2019.9126"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-026-02786-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02786-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02786-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:38:50Z","timestamp":1770287930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-026-02786-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2786"],"URL":"https:\/\/doi.org\/10.1186\/s13014-026-02786-0","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures for the subjects involved in this study were in accordance with the Declaration of Helsinki (October 2024 revision). The study was approved by the Institutional Review Board of Shandong Cancer Hospital (ethical number: SDTHEC2024011037), and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}